Treatment of Disorders Associated with G protein-Coupled Receptor 35 (GPR35)

Abood, M., Zhao, P., Barak, L., & Seltzman, H. (2015). IPC No. U.S. Treatment of Disorders Associated with G protein-Coupled Receptor 35 (GPR35). (U.S. Patent No. 9040583).

Abstract

Compounds are provided having agonistic activity against G protein-coupled receptor 35 (GPR35). The compounds are useful for providing antinociception, providing neuroprotection in case of stroke or ischemia, or treating gastric inflammation.

Download/Explore

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

"Show Me the Energy Costs"
Article

Effectiveness of interventions for the remediation of lead-contaminated soil to prevent or reduce lead exposure-A systematic review
Article

Variation in estimates of heat-related mortality reduction due to tree cover in US cities
Article

Promoting reproducibility and increased collaboration in electric sector capacity expansion models with community benchmarking and intercomparison efforts